150 related articles for article (PubMed ID: 28078756)
1. Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.
Moulis G; Lapeyre-Mestre M; Palmaro A; Sailler L
J Thromb Haemost; 2017 Apr; 15(4):785-791. PubMed ID: 28078756
[TBL] [Abstract][Full Text] [Related]
2. Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.
Moulis G; Lapeyre-Mestre M; Mahévas M; Montastruc JL; Sailler L
Am J Hematol; 2015 Apr; 90(4):301-5. PubMed ID: 25557586
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
[TBL] [Abstract][Full Text] [Related]
4. Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study.
Moulis G; Lapeyre-Mestre M; Montastruc JL; Sailler L
Autoimmun Rev; 2015 Feb; 14(2):168-73. PubMed ID: 25461471
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.
Moulis G; Palmaro A; Sailler L; Lapeyre-Mestre M
PLoS One; 2015; 10(11):e0142217. PubMed ID: 26559054
[TBL] [Abstract][Full Text] [Related]
6. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.
Deshayes S; Khellaf M; Zarour A; Layese R; Fain O; Terriou L; Viallard JF; Cheze S; Graveleau J; Slama B; Audia S; Cliquennois M; Ebbo M; Le Guenno G; Salles G; Bonmati C; Teillet F; Galicier L; Lambotte O; Hot A; Lefrère F; Mahévas M; Canoui-Poitrine F; Michel M; Godeau B
Am J Hematol; 2019 Dec; 94(12):1314-1324. PubMed ID: 31489694
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
Moulis G; Lapeyre-Mestre M; Adoue D; Sailler L
Rev Med Interne; 2017 Jul; 38(7):444-449. PubMed ID: 28131440
[TBL] [Abstract][Full Text] [Related]
9. The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study.
Chandan JS; Thomas T; Lee S; Marshall T; Willis B; Nirantharakumar K; Gill P
J Thromb Haemost; 2018 Mar; 16(3):474-480. PubMed ID: 29297977
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and predictors of treatment responses and complications in immune thrombocytopenia.
Ong SY; Tan CW; Ramya V; Malik AA; Lee XH; Hwang JCC; Yang Y; Ng HJ; Lee LH
Ann Hematol; 2021 Mar; 100(3):645-651. PubMed ID: 33515047
[TBL] [Abstract][Full Text] [Related]
11. Fulminant sepsis in adults splenectomized for idiopathic thrombocytopenic purpura.
Rodeghiero F; Frezzato M; Schiavotto C; Castaman G; Dini E
Haematologica; 1992; 77(3):253-6. PubMed ID: 1427432
[TBL] [Abstract][Full Text] [Related]
12. Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia.
Lozano ML; Godeau B; Grainger J; Matzdorff A; Rodeghiero F; Hippenmeyer J; Kuter DJ
Expert Rev Hematol; 2020 Dec; 13(12):1319-1332. PubMed ID: 33249935
[No Abstract] [Full Text] [Related]
13. Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990-2002.
Langley JM; Dodds L; Fell D; Langley GR
BMC Infect Dis; 2010 Jul; 10():219. PubMed ID: 20649965
[TBL] [Abstract][Full Text] [Related]
14. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.
Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Derumeaux H; Adoue D
Am J Hematol; 2014 Jan; 89(1):41-6. PubMed ID: 24038066
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study.
Podstawka J; Wall E; Bolster L; Patterson JM; Goodyear MD; Rydz N; Sun HL
Thromb Res; 2022 Dec; 220():5-11. PubMed ID: 36257098
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoepidemiology of Immune Thrombocytopenia: protocols of FAITH and CARMEN studies.
Moulis G; Sailler L; Adoue D; Lapeyre-Mestre M
Therapie; 2014; 69(5):437-48. PubMed ID: 25285364
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.
Pasa S; Altintas A; Cil T; Danis R; Ayyildiz O
J Thromb Thrombolysis; 2009 Apr; 27(3):329-33. PubMed ID: 18311541
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of pneumococcal vaccination in adult immune thrombocytopenia patients exposed to rituximab or to splenectomy.
Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Adoue D
Eur J Haematol; 2013 May; 90(5):438-9. PubMed ID: 23444912
[No Abstract] [Full Text] [Related]
19. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
[TBL] [Abstract][Full Text] [Related]
20. Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
Giese C; Mereckiene J; Danis K; O'Donnell J; O'Flanagan D; Cotter S
Vaccine; 2016 Jul; 34(32):3657-62. PubMed ID: 27255466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
